Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 36 Neoplasms 8 HER2-positive Breast Cancer 4 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 3 Salivary Gland Neoplasms 2 Pathologic Complete Response 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Hematologic Neoplasms 2 HER2-positive Early Breast Cancer 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Lymphoproliferative Disorders 1 Lung Neoplasms 1 Liver Neoplasms 1 Hemangiosarcoma 1 Heart Failure 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 2 dapagliflozin 2 Rituximab 2 pertuzumab 1 pegfilgrastim 1 obinutuzumab 1 nicotinamide-beta-riboside 1 acalabrutinib 1 Vincristine 1 Valsartan 1 Trastuzumab 1 Standard of Care 1 Specimen Handling 1 Pyruvic Acid 1 Prednisolone 1 Practice Guidelines as Topic 1 Ogivri 1 Mesenchymal Stem Cell Transplantation 1 Lenalidomide 1 Eplerenone 1 Electronic Health Records 1 Echocardiography 1 Doxorubicin 1 Dexrazoxane 1 Cyclophosphamide 1 Cardiac Resynchronization Therapy 1 Angiotensin-Converting Enzyme Inhibitors 1 Adrenergic beta-Antagonists 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Heart Failure × pertuzumab × Clear all

NCT04680442 2025-04-06

SCHOLAR-2

Population Health Research Institute

Phase 2 Recruiting

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡